Manuel Lopez-Figueroa
Direktor/Vorstandsmitglied bei ORYZON GENOMICS S.A.
Aktive Positionen von Manuel Lopez-Figueroa
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ORYZON GENOMICS S.A. | Direktor/Vorstandsmitglied | 11.05.2020 | - |
| Independent Dir/Board Member | 11.05.2020 | - | |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Berater | 07.07.2021 | - |
| Private Equity Investor | 01.07.2001 | 01.07.2021 | |
Imidomics, Inc.
 Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | Geschäftsführer | 01.06.2015 | - |
| Cantero Therapeutics, Inc. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
| Gründer | 01.01.2018 | - | |
| Zulia Biotech, Inc. | Direktor/Vorstandsmitglied | - | - |
Nina Capital SGEIC SA
 Nina Capital SGEIC SA Investment ManagersFinance Nina Capital SGEIC SA (Nina Capital) is a venture capital firm founded in 2019 by Marta Gaia Zanchi. It is headquartered in Barcelona, Spain. | Berater | 01.01.2019 | - |
Karriereverlauf von Manuel Lopez-Figueroa
Ausbildung von Manuel Lopez-Figueroa
| University of Copenhagen | Doctorate Degree |
| La Laguna University Of | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Spanien | 4 |
| Dänemark | 2 |
Operativ
| Director/Board Member | 3 |
| Consultant / Advisor | 2 |
| Private Equity Investor | 1 |
Sektoral
| Finance | 3 |
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ORYZON GENOMICS S.A. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Finance |
Imidomics, Inc.
Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | Health Technology |
| Cantero Therapeutics, Inc. | |
| Zulia Biotech, Inc. | |
Nina Capital SGEIC SA
Nina Capital SGEIC SA Investment ManagersFinance Nina Capital SGEIC SA (Nina Capital) is a venture capital firm founded in 2019 by Marta Gaia Zanchi. It is headquartered in Barcelona, Spain. | Finance |
- Börse
- Insiders
- Manuel Lopez-Figueroa
- Erfahrung
